Main content

Guinea-Bissau suspends US-backed hepatitis vaccine trial

Guinea-Bissau suspends hepatitis B vaccine trial for newborns amid ethical concerns, and Nigerian legend Fela Kuti to posthumously receive Grammy lifetime achievement award

The military government in Guinea-Bissau has suspended a scientific trial for the hepatitis B vaccine administered to newborns. The trial is funded by the US Centers for Disease Control and Prevention to the tune of $1.6 million and conducted by scientists from the University of Southern Denmark. The Bissau government says the study will be subjected to a technical and ethical review.

And, almost three decades after his death, Nigeria's Fela Kuti, who pioneered the Afrobeats music genre, is set to be feted with a Grammy Lifetime Achievement Award.

Presenter: Nkechi Ogbonna
Producers: Bella Twine, Blessing Aderogba and Mark Wilberforce
Technical Producer: Terry Chege
Senior Producer: Charles Gitonga
Editors: Samuel Murunga and Maryam Abdalla

Available now

23 minutes

More episodes

See all episodes from Focus on Africa

Featured

  • .

Podcast

  • Focus on Africa

    Two essential stories to round off your working day. Explaining the news from Africa